SCM
BNTC icon

Suvretta Capital Management’s Benitec Biopharma BNTC Stock Holding History

Suvretta Capital Management’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$155M Hold
11,548,351
– – 2.83% 7
2026
Q1 		$123M Hold
11,548,351
– – 3.14% 7
2025
Q4 		$156M Buy
11,548,351
+1,671,845
+17% +$23.1M 3.19% 4
2025
Q3 		$139M Hold
9,876,506
– – 3.55% 3
2025
Q2 		$116M Hold
9,876,506
– – 3.48% 7
2025
Q1 		$128M Buy
9,876,506
+916,497
+10% +$11.1M 4.77% 4
2024
Q4 		$113M Buy
8,960,009
+130,956
+1% +$1.41M 3.86% 6
2024
Q3 		$81.1M Buy
8,829,053
+7,137,763
+422% +$63.9M 2.6% 9
2024
Q2 		$11.8M Buy
1,691,290
+1,487,070
+728% +$11M 0.43% 47
2024
Q1 		$1.07M Hold
204,220
– – 0.04% 86
2023
Q4 		$660K Hold
204,220
– – 0.03% 82
2023
Q3 		$617K Buy
204,220
+158,985
+351% +$494K 0.03% 82
2023
Q2 		$3.12M Hold
45,235
– – 0.17% 66
2023
Q1 		$161K Hold
45,235
– – 0.01% 94
2022
Q4 		$131K Hold
45,235
– – 0.01% 88
2022
Q3 		$286K Hold
45,235
– – 0.01% 71
2022
Q2 		$892K Hold
45,235
– – 0.03% 85
2022
Q1 		$1.8M Hold
45,235
– – 0.05% 76
2021
Q4 		$2.02M Hold
45,235
– – 0.04% 80
2021
Q3 		$2.75M Hold
45,235
– – 0.05% 90
2021
Q2 		$3.27M Buy
+45,235
New +$3.54M 0.05% 99

Other funds holding BNTC

JT
Jupiter Topco New York $245B AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Suvretta Capital Management's BNTC Position: Q2 2026 in Review

Suvretta Capital Management held its Benitec Biopharma (BNTC) position steady in Q2 2026 at 11,548,351 shares worth $155M. The position accounts for 2.83% of the portfolio, ranked #7.

Suvretta Capital Management first reported a position in BNTC in Q2 2021 and has held it in 21 quarters since. The position peaked at $156M in Q4 2025. 87 funds tracked by Wall St. Rank hold BNTC as of Q2 2026.

  • Suvretta Capital Management held 11,548,351 shares of Benitec Biopharma worth $155M as of Q2 2026.
  • Suvretta Capital Management left its Benitec Biopharma share count unchanged in Q2 2026.
  • Benitec Biopharma made up 2.83% of Suvretta Capital Management's portfolio in Q2 2026, its #7 holding.
  • Suvretta Capital Management first reported a position in Benitec Biopharma in Q2 2021 and has held it in 21 quarters since.
  • Suvretta Capital Management's Benitec Biopharma position peaked at $156M in Q4 2025.
  • 87 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2026.

Based on Suvretta Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.